29 results
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
2 Nov 21
Continues Strong Execution of Strategic Growth & Transformation Plans
8:40am
for sustainable growth and profitability. I want to thank all of our 2,400 Myriad Genetics teammates for their commitment to advancing the health … sustainable and profitable results for all of our shareholders.”
Business Performance and Highlights:
Women’s Health
In the Myriad Women’s Health
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
13 Aug 20
Myriad Genetics Appoints Paul J. Diaz as President and Chief Executive Officer
4:26pm
a tremendous opportunity to transform
its business, and strategically position itself for sustainable, profitable growth. We will look to leverage … for sustainable, profitable growth; and the Company’s strategic directives under the caption “About Myriad Genetics.” These “forward-looking statements
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
3 May 23
Results of Operations and Financial Condition
4:06pm
and sustainable 10%+ annual organic growth as we enter 2024 based on our progress."
Financial and Operational Highlights:
Test volumes of 349,353 … , the company's goal of profitability by the fourth quarter 2023 and sustainable 10%+ annual organic growth as the company enters 2024, and statements
8-K
EX-99.1
MYGN
Myriad Genetics, Inc.
9 Nov 20
Test Volumes Reach 90% of Pre-COVID-19 Level at End of Quarter
8:02am
transformation plan to drive sustainable long-term growth and profitability. I believe Myriad Genetics is positioned for commercial success with a strong market … relating to sustainable growth and profitability; the more than $40 million in annualized cost savings to be implemented over the next nine months
8-K
MYGN
Myriad Genetics, Inc.
3 May 23
Results of Operations and Financial Condition
4:06pm
and sustainable 10%+ annual organic growth as the company enters 2024, and statements relating to the planned launch of a new hereditary cancer
8-K
EX-99.1
wrbt1r rj1
4 Nov 08
Results of Operations and Financial Condition
12:00am
8-K
0frneuqzqm68xdlhb
6 Nov 23
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
qp2b7mhx fcap0
15 Oct 20
Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate
7:18am
8-K
EX-99.1
s9y54no440u ekwkbt
6 Feb 20
Myriad Announces Leadership Transition
5:00pm
8-K
EX-99.2
mo45ch 3gpi
9 Nov 20
Test Volumes Reach 90% of Pre-COVID-19 Level at End of Quarter
8:02am
8-K
EX-99.1
3m94ieplrqs
3 Aug 23
Results of Operations and Financial Condition
4:05pm
DEFA14A
8h0hjin
15 Oct 20
Additional proxy soliciting materials
7:20am
8-K
EX-99.1
c7aje ri579nb
6 Nov 23
Results of Operations and Financial Condition
4:05pm
8-K
8vjeid9
3 Aug 23
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
an2prkz
3 Aug 21
Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans
7:05am
8-K
EX-99.1
o8yff0r1gplq y7pg920
11 Jan 22
Results of Operations and Financial Condition
4:16pm
8-K
EX-99.1
3patz9mjaf 4vpvbd
1 Nov 22
Myriad Genetics Reports Third Quarter Financial Results
9:03am